• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • News & Updates
  • Tools & Resources
Home Tools & Resources

Tools & Resources

Use HepVu in your work and to learn more about the viral hepatitis epidemic. From downloadable data sets to educational infographics, HepVu offers a variety of materials to help illustrate the impact of hepatitis in the U.S.

Download Infographics

Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025

Download

COVID-19 & Viral Hepatitis Care

Download

Liver Cancer and Viral Hepatitis

Download

Hepatitis Testing Day 2020

Download

National Hispanic Hepatitis Awareness Day 2020

Download

Hepatitis C Testing Graphics

Download

Tennessee Perinatal Infographics

Download

HepVu Launches New Data Visualizing Hepatitis C’s Impact on Americans of Different Ages, Sexes, and Races

Download

African American Hepatitis C Action Day

Download

Hepatitis Testing Day

Download

Hepatitis Testing Day (Spanish)

Download

The Opioid Epidemic and Hepatitis C in the United States

Download

Hepatitis Testing Day 2018

Download

Hepatitis C Infographic

Download

Hepatitis B Infographic

Download

Data Methods

Learn more about the data used on HepVu

Visit Data Methods
Deeper Look: Opioids

Deeper Look: Opioids

The opioid crisis is one of the greatest public health challenges facing the U.S., causing an unprecedented surge in drug overdose deaths, and fueling the rapid rise in new Hepatitis C infections from injection drug use in communities across the country.

Learn More
Deeper Look: Viral Hepatitis Elimination

Deeper Look: Viral Hepatitis Elimination

In January 2021, the U.S. Department of Health and Human Services (HHS) released its Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025. The plan outlines objectives and strategies to aid stakeholders—researchers, policy makers, health care providers, advocacy groups, and patients—in working together to eliminate viral hepatitis as a public health threat in the U.S.

Learn More

Webinars and One-Pagers

HepVu Webinar: Harm Reduction Services in the Time of COVID-19

Learn More

HepVu Webinar: The Impact of the COVID-19 Pandemic on Viral Hepatitis

Learn More

HepVu and LCOA Joint Webinar: The Impact of Hep C in the USA

Learn More

HepVu Webinar: Best Practices & Challenges in Hepatitis C Surveillance

Learn More

HepVu One-Pager

Learn More

Sign up for HepVu updates:

Footer

HepVu HepVu
Facebook Twitter
  • About
  • FAQ
  • Data Methods

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

2021 © HepVu. ALL RIGHTS RESERVED.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.